It was finally shown in vivo that lnc-MMP2-2 knockdown significantly inhibited the occurrence of brain metastases, and TGF-β1 pre-treatment of the NSCLC cell line increased the rate of brain metastases. This evidence concerns the gene TGFB1 and non-small cell lung carcinoma.